Made to Save statement on recent Johnson and Johnson COVID-19 vaccine pause
Today the FDA and CDC issued a recommendation to pause the use of the Johnson & Johnson vaccine while they review rare cases of blood clots in six recipients (a rate of less than 1 in 1 million) within two weeks of receiving the J&J vaccine.
Close to 7 million people in the United States have received the Johnson & Johnson vaccine so far. Today’s recommendation to pause administration of the vaccine shows that the FDA and CDC’s process of prioritizing efficacy and safety is working as it should.
As the CDC and FDA further review the science, we remain focused on increasing access to the COVID-19 vaccines and trusted information, especially in the communities affected most by the pandemic.
We know today’s news raises questions for those who got or are scheduled for the Johnson & Johnson vaccine. More info is coming. In the meantime, sites are switching to Moderna or Pfizer during the pause.
We encourage you to keep your vaccine appointment, make an appointment if you haven’t yet, and tell family and friends to do the same. Individual vaccinations are our only path to getting back to the moments and people we cherish most.